Although there is substantial immune cell infiltration into the tumor microenvironment, the overactivation of immune checkpoints, particularly the enhanced PD-1/PD-L1 signaling pathway, suppresses the function of effector T cells, preventing them from effectively mounting an anti-tumor response [63]. This evidence concerns the gene CD274 and neoplasm.